Clinical Trial Update: Cannabidiol for Bipolar Depression (CBD-BD) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating cannabidiol (CBD) for bipolar depression is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University of British Columbia | Conditions: Bipolar Disorder | Phase 3 | Status: RECRUITING